CD4 and cancer: In a predictive point of view and based on determined cut-offs, high frequency of CD8+CD45RChigh and low frequency of CD4+CD45RChigh T cells allowed to predict a >20-fold and a nearly 4-fold increased risk of developing AR and cancer, respectively, after adjustment on classical risk factors.